Liver Transplant for Liver Cancer in Turkey: Who Is Eligible and What to Expect

Today, treating liver cancer is no longer just a surgical protocol. It has become a complete journey toward a new chance at life. This guide explains, clearly and step by step, how a liver transplant is used to treat liver cancer in Turkey. You will learn how this advanced surgery can offer real hope, and which patients are eligible for this treatment.

We know that facing liver cancer is not just a medical challenge. It is an emotional journey, where worry and the search for hope go hand in hand. In those difficult moments, what matters most is finding a place that offers both medical safety and the sincere human support you deserve.

1. When Is a Liver Transplant the Right Treatment for Liver Cancer?

A liver transplant is not performed for every patient with liver cancer. Candidates are carefully selected using scientific criteria designed to give the best chance of cure and the lowest risk of the cancer coming back (recurrence) after surgery.

A liver transplant is usually recommended for patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer, who also have advanced cirrhosis or partial liver failure. In these patients, surgically removing only the tumor (resection) is unsafe or unlikely to work.

1.1 The Milan Criteria for Liver Transplantation:

• A single tumor no larger than 5 cm in diameter, or up to 3 tumors, none larger than 3 cm.
• No spread outside the liver (extrahepatic metastasis), for example to the lungs or bones.
• No invasion of major blood vessels (macrovascular invasion), such as the portal vein or hepatic veins.

Patients who meet these criteria have five-year survival rates of more than 75–80% after transplantation. These results are comparable to those of transplants performed for liver disease without cancer.

1.2 Expanded Criteria:

In recent years, thanks to advances in surgical techniques and post-transplant immune management, some centers around the world, including leading transplant centers in Turkey, have begun using expanded criteria such as:

• UCSF criteria (University of California, San Francisco): a single tumor up to 6.5 cm, or 2–3 tumors with none larger than 4.5 cm and a total diameter of 8 cm or less.
• Up-to-seven criteria: the number of tumors plus the diameter of the largest tumor (in cm) adds up to 7 or less, with no microvascular invasion.

These expanded criteria are only applied after a careful assessment of the tumor’s biology. This includes the alpha-fetoprotein (AFP) level, a tumor marker measured in the blood, and how the tumor responds to initial treatment. This approach allows more patients to qualify without harming outcomes.

1.3 When Is a Liver Transplant Not Recommended?

A liver transplant is not performed in the following situations:

• The cancer has spread outside the liver (extrahepatic metastases).
• The tumor has extensively invaded major blood vessels.
• The tumor is very aggressive and does not respond to initial treatment.
• The patient’s general health is so poor that surgery is not possible.

In these cases, doctors use palliative or preparatory treatments, such as transarterial chemoembolization (TACE) or thermal ablation. The goal is to shrink the tumor and, where possible, bring the patient back within transplant criteria later.

1.4 The Role of the Medical Team in the Transplant Decision:

Choosing the right patient for a liver transplant is never one doctor’s decision. It is made by a multidisciplinary team that includes a liver transplant surgeon, an oncologist, an interventional radiologist, a hepatologist (liver specialist) and a transplant immunologist. The team reviews each case based on:

• Tumor characteristics (size, number, location and vascular invasion)
• Overall liver function (Child-Pugh classification)
• Blood markers (AFP and liver function tests)
• Response to initial treatment

The result is a treatment plan tailored to the patient. It may include preparatory treatment before the transplant, direct placement on the transplant list, or continued interventional treatment until the patient is fully eligible for surgery.

2. Why a Liver Transplant May Outperforms Other Liver Cancer Treatments?

For liver cancer patients with advanced cirrhosis or liver failure, a liver transplant is the most complete and effective treatment. It does not just remove the tumor. It also treats the underlying liver disease that allowed the cancer to develop in the first place. This is what sets it apart from all other treatments, which only remove or destroy the tumor locally.

2.1 Removing Both the Tumor and Its Source:

A partial surgery (hepatic resection) removes the tumor but leaves behind the cirrhotic liver tissue, which can develop new tumors. A liver transplant, by contrast, replaces the entire diseased liver with a healthy one.

As a result, the risk of recurrence is much lower, especially in patients within the Milan criteria or carefully monitored expanded criteria. Studies show recurrence rates after transplantation of less than 10–15%, compared with more than 50% after partial resection in patients with chronic cirrhosis.

2.2 Restored Liver Function After Transplant:

Most patients with hepatocellular carcinoma have a partially or fully cirrhotic liver. This puts them at risk of liver failure after any major surgery.

A liver transplant gives the patient a new, healthy liver that brings the liver’s vital functions back to near-normal levels: metabolism, detoxification, protein production and blood clotting. This improves quality of life and also allows the patient to tolerate any additional treatment later, if needed.

2.3 Better Long-Term Results Than Other Options:

Comparative studies show that, for HCC patients who meet the selection criteria, a liver transplant achieves the best long-term survival of all treatment options:

• Five-year survival: 75–85%
• Tumor-free (recurrence-free) survival: more than 70%

By comparison, these figures fall to around 40–50% after partial resection, and below 30% with locoregional or systemic treatments.

2.4 Eliminating Cirrhosis and Chronic Inflammation:

Liver cancer usually develops in a liver damaged by chronic cirrhosis or long-standing viral hepatitis (hepatitis B or C). Surgery or local treatments do not change this environment, so the risk of a new tumor remains.

A liver transplant replaces the diseased tissue with completely healthy tissue. This gives the patient a fresh start without cirrhosis and restores the liver’s normal function.

2.5 Advances That Have Improved Transplant Results:

Over the past two decades, liver transplantation has advanced enormously, making the procedure safer and its results more reliable. Key advances include:

• Improved immunosuppression protocols, which reduce the risk of rejection without over-suppressing the immune system
• Living donor liver transplantation (LDLT), which shortens waiting times and improves access to a suitable liver
• Bridging therapy programs, such as TACE and radiofrequency ablation (RFA), which keep the tumor under control until the transplant
• Careful follow-up with regular AFP tests and imaging to detect any recurrence early

2.6 Better Quality of Life After Transplant:

Beyond treating the tumor, patients usually notice a major improvement in daily life after the transplant: ascites (fluid in the abdomen) disappears, appetite and energy improve, and they regain full physical function.

With regular immunosuppressive care and ongoing follow-up, most patients live a normal life, with a transplanted liver that works well for many years.

3. The Steps of a Liver Transplant for Liver Cancer in Turkey

A liver transplant for liver cancer is one of the most complex operations in modern surgery. It requires careful planning and close coordination between several specialist teams. The goal is to replace the diseased liver with a healthy liver from a living or brain-dead donor, removing the tumor completely and restoring the liver’s vital functions without complications.

3.1 Pre-Surgery Preparation:

Before surgery, the patient goes through a full assessment, including:

• Complete blood tests to assess liver function, kidney function and blood clotting
• Multiphase (triphasic) CT or MRI to show the location and number of tumors and how they relate to blood vessels
• Heart and lung tests to confirm the patient can tolerate major surgery
• Psychological and nutritional assessment, because a transplant requires lifelong commitment to immunosuppressive medicines and careful follow-up

For a living donor liver transplant, the donor also goes through a detailed assessment (blood tests, imaging and compatibility tests) to make sure they are healthy and fit to donate part of their liver.

In this type of transplant, a lobe of the liver (usually the right or left lobe) is removed from a healthy donor and transplanted into the patient. The liver has a remarkable ability to regenerate: the transplanted part gradually grows to work as a full liver, and the donor’s liver also regenerates within a few weeks.

In Turkey, liver transplants for international patients are performed only from living donors, and the donor must be a relative of the patient, up to the fourth degree of kinship.

3.2 The Transplant Procedure:

• Stage 1: The diseased liver is completely removed (hepatectomy), together with the tumor and all cirrhotic tissue.
• Stage 2: The new liver from the donor is prepared and connected to the patient’s blood vessels: the portal vein, the hepatic artery, and the hepatic vein (which is joined to the inferior vena cava). The bile duct is then connected. These connections are made with very high precision, often using surgical magnification.
• Stage 3: Blood flow (perfusion) and bile flow are checked immediately to confirm that the new liver is working.

The operation usually takes 8 to 12 hours and is performed in operating rooms equipped with advanced monitoring technology.

3.3 After Surgery: Intensive Care and Monitoring:

After the transplant, the patient is moved to the surgical intensive care unit (ICU) for a few days, then to a transplant ward for several weeks. During this stage:

• The new liver’s function is monitored with daily blood tests (AST, ALT, bilirubin and INR)
• The patient receives immunosuppressive medicines (such as tacrolimus, mycophenolate mofetil and prednisone) to prevent rejection of the new liver
• Regular Doppler ultrasound or CT scans check blood flow and rule out vascular or biliary complications

3.4 Recovery and Life After Transplant:

Patients usually stay in hospital for 2 to 4 weeks, and recovery happens gradually. After discharge, regular follow-up is needed to adjust immunosuppressive doses and watch for any sign of recurrence or rejection. By following the treatment plan, diet and medical advice, patients can live a normal life with a new liver that works fully.

3.5 Success Rates of Liver Transplants for Liver Cancer in Turkey:

Thanks to extensive surgical experience and modern follow-up systems, success rates at Turkish transplant centers exceed 90% in the first year, with long-term results comparable to the best centers in Europe and the United States.

Turkish hospitals are among the most experienced in the world in living donor liver transplantation, performing hundreds of procedures each year with very high safety standards. This makes Turkey a strong choice for liver cancer patients who are eligible for a transplant.

4. When Is an Immediate Liver Transplant Postponed?

Not every patient diagnosed with liver cancer is immediately eligible for a liver transplant in Turkey. Some patients are temporarily excluded from the transplant list because of tumor size, the number of nodules or their overall liver condition. Thanks to advances in interventional treatments, these patients can often be prepared for a transplant through downstaging therapy or bridging therapy.

4.1 What Is Downstaging Therapy?

Downstaging aims to shrink the tumor or reduce the number of nodules, so that a patient who was outside the transplant criteria (such as the Milan criteria) comes back within them. Precise interventional procedures are used, including:

• Transarterial chemoembolization (TACE): chemotherapy delivered directly into the tumor through the hepatic artery, while the tumor’s blood supply is blocked
• Transarterial radioembolization (TARE / Y-90): tiny radioactive particles (yttrium-90) delivered to the tumor
• Thermal ablation using microwave ablation (MWA) or radiofrequency ablation (RFA), which destroys the tumor with heat

The goal is to control the tumor and stop it from growing during the waiting period, with regular assessment through imaging and AFP tests. When the tumor responds well and is back within the accepted criteria, the patient is placed on the transplant list again.

4.2 What Is Bridging Therapy?

Bridging therapy is used for patients who are already eligible for a transplant but must wait until a suitable liver is available (from a living or deceased donor).

Its purpose is to stop the tumor from growing or moving outside the criteria during the wait. The most common techniques are:

• Repeated TACE to control tumor growth
• Thermal ablation for small tumors near the surface of the liver
• Stereotactic body radiation therapy (SBRT), a highly targeted form of radiotherapy, in selected cases where the tumor is hard to reach with interventional procedures

Experience at Turkish centers has shown that using these protocols before transplantation improves success rates after surgery and reduces the risk of early recurrence.

4.3 Close Monitoring While Waiting:

While waiting for a transplant, the patient has regular follow-up every 6–8 weeks, including:

• Imaging (multiphase CT or MRI)
• AFP measurement as a marker of tumor activity
• Ongoing assessment of liver function, Child-Pugh class and MELD score

If there are signs that the tumor is growing or no longer under control, the patient is reassessed immediately and the plan is adjusted, either by repeating the interventional treatment or by moving to other treatment options.

4.4 Turkey’s Experience in Managing This Stage:

Thanks to their integrated teams, Turkish centers have extensive experience in selecting patients carefully and managing the period before transplantation.

All downstaging and bridging treatments are available within the same hospital. This means interventional radiologists and transplant surgeons can work together closely.

This close teamwork is what raises success rates, and it means that many cases once considered unsuitable for a transplant can be fully treated after proper preparation.

Conclusion

Treating liver cancer with a liver transplant in Turkey is more than a complex surgical procedure. It is a decisive step and a real journey of hope toward recovery, made possible by your courage and your trust in a specialist medical team. Turkey today offers an advanced treatment environment, world-class surgical techniques and compassionate care that make this difficult medical challenge less frightening and more reassuring for you and your family.

If you or a family member is facing this challenge, do not hesitate to seek medical advice early. Every day counts when it comes to controlling the disease and starting the path to recovery.

At Safak Medical, we do more than coordinate treatment. We are with you at every step of your journey:

• Review and assessment: we carefully review your medical file and present it to leading senior professors.
• Complete coordination: we organize your medical tests and help choose the hospital and surgeon best suited to your case.
• Ongoing support: we provide close, continuous follow-up before, during and after surgery and treatment, to support a safe and complete recovery.

Contact us today and let us help you turn worry into hope, and fear into peace of mind, because your health deserves the best medical care in the world.